{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:40:48Z","timestamp":1712450448923},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1053\/j.seminoncol.2011.03.019","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T00:38:03Z","timestamp":1306197483000},"page":"327-334","source":"Crossref","is-referenced-by-count":0,"title":["Monoclonal Gammopathy of Undetermined Significance Versus Smoldering Myeloma: Is Active Surveillance Enough?"],"prefix":"10.1053","volume":"38","author":[{"suffix":"III","given":"W. Edward","family":"Jordan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Emmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2011.03.019_bib1","unstructured":"Multiple Myeloma. Practice guidelines in oncology v.3.2010. National Comprehensive Cancer Network. www.nccn.org."},{"key":"10.1053\/j.seminoncol.2011.03.019_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteris for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib4","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib7","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2003-09-3064","article-title":"Characterization of clonogenic multiple myeloma cells","volume":"103","author":"Matsui","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.1994.tb04908.x","article-title":"Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma","volume":"87","author":"Witzig","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib10","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells","volume":"110","author":"Perez-Persona","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib11","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jcb.22403","article-title":"Pathogenesis of myeloma bone disease","volume":"109","author":"Roodman","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2007-08-108357","article-title":"Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma","volume":"111","author":"Dispenzieri","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.42.3.193","article-title":"Neuropathy, amyloidosis, and monoclonal gammopathy","volume":"42","author":"Fitting","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02427609","article-title":"Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient","volume":"19","author":"Grassi","year":"1998","journal-title":"Ital J Neurol Sci"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"MGUS and SMM IMWG consensus perspectives: risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2141.2007.06873.x","article-title":"Monoclonal gammopathy of undetermined significance and smouldering MM: emphasis on risk factors for progression","volume":"139","author":"Kyle","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib20","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1158\/1078-0432.CCR-09-1575","article-title":"Prevention of progression in MGUS","volume":"15","author":"Rajkumar","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib21","article-title":"Multicenter, randomized, open label, phase III trial of lenalidomide\/dexamethasone (Len-Dex) versus therapeutic abstention in SMM at high risk of progression to symptomatic MM: results of first interim analysis","author":"Mateos","year":"2009","journal-title":"Proc Am Soc Hematol"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib22","unstructured":"www.leukemia-lymphoma.org."},{"key":"10.1053\/j.seminoncol.2011.03.019_bib23","article-title":"African-American multiple myeloma patients have a better survival than Caucasian patients: a population-based study including 28,636 patients","author":"Landgren","year":"2009","journal-title":"Proc Am Soc Hematol"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2009-03-207233","article-title":"Familial multiple myeloma","volume":"114","author":"Lynch","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa0708704","article-title":"Familial myeloma","volume":"359","author":"Lynch","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2011.03.019_bib26","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00983346."},{"key":"10.1053\/j.seminoncol.2011.03.019_bib27","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00099047."}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775411000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775411000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:20:53Z","timestamp":1712449253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775411000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0093775411000893"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2011.03.019","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}